GenAI ROI: Why usage isn't value and CEOs need outcome owners

“Many of our employees are already using GenAI” is not a success story. It’s an activity report. The difference may sound small, but for CFOs, boards, and CEOs, it’s enormous.

Many companies have integrated GenAI into their organization, but not into value creation. They have tools, pilot groups, prompt libraries, internal champions, and impressive anecdotes. What's often missing is the simplest and most difficult question: Where is the measurable value?

Adoption is not yet a result

GenAI can be made visible surprisingly quickly. Login numbers increase. Teams experiment. Use case lists grow. In presentations, this looks like progress.

Then someone on the board asks: Which processes have become faster, better, or less risky as a result? Who owns the outcome? What costs are we avoiding? What quality is improving? Which errors are decreasing?

Suddenly, screenshots are no longer enough.

The problem isn't that GenAI doesn't create value. The problem is that value doesn't automatically arise simply by using a tool. Value is created when processes are redesigned, standards are set, responsibilities are clarified, and effects are measured.

Without this discipline, GenAI becomes the next shadow IT: many small optimizations, little scalability, unclear risks, and an organization that appears busy but is not better managed.

The ROI gap is a leadership gap.

The central thesis is uncomfortable: Without ROI discipline, GenAI will not become a productivity engine, but rather an organizational debt.

This debt is rarely immediately reflected in the balance sheet. It manifests itself in duplicate tools, unclear data flows, inconsistent results, compliance issues, quality risks, and a lack of focus. Everyone is building their own solution. Everyone is optimizing locally. The company is losing its global perspective.

Many leadership teams reassure themselves with the phrase: "We're in." But being in is not a strategy. It's mere presence.

Strategy begins with three decisions: Which outcomes truly matter? Which use cases take priority? Who is responsible for the result, not just the implementation?

The wrong metrics drive the wrong behavior.

Usage is a leading indicator. It shows that something is happening. It doesn't prove value.

When adoption becomes the target metric, you get adoption. More users, more prompts, more internal showcases. This can be helpful, but it can also miss the point. Goodhart's Law applies: When a measure becomes the goal, it loses its quality as a measure.

Therefore, GenAI governance requires different key performance indicators (KPIs). For prioritized use cases, at least three dimensions should be visible: time, quality, and risk.

Time: Will lead time be reduced or capacity freed up? Quality: Will the error rate decrease or consistency increase? Risk: Will compliance, safety, or error costs be better controlled?

If a use case can't provide any answers, it might be interesting. But it's not yet ready for investment.

From Use Case Graveyard to Value Portfolio

Many organizations mistake a wealth of ideas for portfolio quality. Fifty use cases seem ambitious. In reality, they are often a graveyard of good intentions.

Leadership here means doing less, but doing it seriously. Five to seven prioritized use cases, with a clear sequence, measurable outcomes, and a true owner in the process.

The owner isn't automatically IT. Nor is it the Center of Excellence. The owner resides where the process value is created: Sales, Finance, Operations, HR, Legal. Because GenAI value is process value. Whoever isn't responsible for the process can't lead the result.

IT and the Center of Excellence (CoE) provide standards, enablement, and governance. Accountability for results belongs to the line management.

The consequences for CEOs

If GenAI is to deliver value to a company, it doesn't need an even bigger tool demo. It needs a value architecture.

First: Define three key performance indicators (KPIs) for time, quality, and risk for each prioritized use case. Second: Reduce the use case list to a manageable portfolio. Third: Identify outcome owners by name, not by committee.

And above all: Stop portraying adoption as a success. Adoption is the beginning of the work, not its result.

Final thought

GenAI will not fail in many companies because of the models themselves. It will fail because of weak leadership.

The uncomfortable question is: Where does usage currently replace responsibility in your case?

As long as this question remains open, the ROI also remains open.

Relevant podcast episode